Growth Metrics

Insulet (PODD) Free Cash Flow Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -1.82%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 226.77%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 9.73%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -51.69%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -109.40%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 133.09%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 363.84%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 108.16%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 29.12%
10 Insulet 10.37 Bn 9.89 Bn 529.10 Mn 101.36%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 101.36%
Dec 31, 2025 78.06%
Sep 30, 2025 60.05%
Jun 30, 2025 212.29%
Mar 31, 2025 -21.37%
Dec 31, 2024 13.13%
Sep 30, 2024 127.30%
Jun 30, 2024 127.21%
Mar 31, 2024 755.00%
Dec 31, 2023 72.20%
Sep 30, 2023 -33.40%
Jun 30, 2023 36.06%
Mar 31, 2023 40.48%
Dec 31, 2022 10.05%
Sep 30, 2022 201.51%
Jun 30, 2022 168.42%
Mar 31, 2022 57.14%
Dec 31, 2021 -24.09%
Sep 30, 2021 -400.00%
Jun 30, 2021 -79.88%
Mar 31, 2021 -226.67%
Dec 31, 2020 154.13%
Sep 30, 2020 -25.94%
Jun 30, 2020 -171.61%
Mar 31, 2020 -93.55%
Dec 31, 2019 -458.31%
Sep 30, 2019 -74.27%
Jun 30, 2019 130.91%
Mar 31, 2019 71.52%
Dec 31, 2018 826.70%
Sep 30, 2018 539.06%
Jun 30, 2018 -1,769.05%
Mar 31, 2018 54.19%
Dec 31, 2017 -123.86%
Sep 30, 2017 236.81%
Jun 30, 2017 388.78%
Mar 31, 2017 -247.40%
Dec 31, 2016 177.73%
Sep 30, 2016 -270.76%
Jun 30, 2016 76.60%
Mar 31, 2016 -74.59%
Dec 31, 2015 -1,218.39%
Sep 30, 2015 262.95%
Jun 30, 2015 117.21%
Mar 31, 2015 -146.82%
Dec 31, 2014 131.29%
Sep 30, 2014 -8.44%
Jun 30, 2014 -212.16%
Mar 31, 2014 -39.89%
Dec 31, 2013 17.52%
Sep 30, 2013 123.01%
Jun 30, 2013 120.10%
Mar 31, 2013 78.60%
Dec 31, 2012 23.09%
Sep 30, 2012 -97.76%
Jun 30, 2012 -16.34%
Mar 31, 2012 1.50%
Dec 31, 2011 6.37%
Sep 30, 2011 71.65%